Last checked at 23 Jul 2021 12:46
Oncimmune signs agreement with major cancer centre to profile patients
Oncimmune signs agreement with major cancer centre to profile patients
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Oncimmune Share News (ONC)
ONC Share
Price
ONC Share
News
ONC Share
Chat
ONC Share
Trades
ONC
Live RNS
ONC Share
Charts
ONC Level 2
Console
ONC Live
Share Price
ONC Broker
Ratings
ONC Directors
Deals
ONC Financial
Diary
ONC
Fundamentals
ONC Short
Positions
ONC
Media
Oncimmune Information
Share Price Information for Oncimmune (ONC)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
24.80
Bid:
24.00
Ask:
25.60
Change:
0.00 (0.00%)
Spread:
1.60 (6.667%)
Open:
0.00
High:
0.00
Low:
0.00
Prev. Close:
24.80
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.23 Jul 2021 09:44
Oncimmune inks research deal with Dana-Farber Cancer Institute
(Sharecast News) - Immunodiagnostics group Oncimmune has signed an autoantibody profiling contract with Dana-Farber Cancer Institute, based in Boston, Massachusetts, it announced on Friday.
Read more22 Jul 2021 19:40
TRADING UPDATES: Tekcapital investee and Puma VCT 13 raise funds
TRADING UPDATES: Tekcapital investee and Puma VCT 13 raise funds
Read more8 Jun 2021 13:11
TRADING UPDATES: Nightcap toasts sales jump after May reopening
TRADING UPDATES: Nightcap toasts sales jump after May reopening
Read more8 Jun 2021 10:57
Oncimmune FY revenues tracking in line with expectations
(Sharecast News) - Immunodiagnostics group Oncimmune said on Tuesday that 2021 full-year revenues were in line with market expectations,
Read more1 Jun 2021 15:51
UK earnings, trading statements calendar - next 7 days
UK earnings, trading statements calendar - next 7 days
Read more5 May 2021 19:20
TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million
TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million
Read more6 Apr 2021 16:54
IN BRIEF: Oncimmune signs separate deals with Roche and Cedars-Sinai
IN BRIEF: Oncimmune signs separate deals with Roche and Cedars-Sinai
Read more6 Apr 2021 09:14
Oncimmune secures contracts with Roche and Cedars-Sinai
(Sharecast News) - Immunodiagnostics group Oncimmune said on Tuesday that it had signed two separate agreements for the use of its newly developed and proprietary Infectious Disease panel with Roche Pharmaceuticals and Cedars-Sinai Medical Center.
Read more25 Mar 2021 16:46
Oncimmune secures GBP9 million in oversubscribed share placing
Oncimmune secures GBP9 million in oversubscribed share placing
Read more25 Mar 2021 11:28
AIM WINNERS & LOSERS: Tandem rises on strong results, positive outlook
AIM WINNERS & LOSERS: Tandem rises on strong results, positive outlook
Read more15 Feb 2021 10:30
Oncimmune Interim Loss Narrows On Higher Revenue And Lower Costs
Oncimmune Interim Loss Narrows On Higher Revenue And Lower Costs
Read more8 Feb 2021 16:09
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
Read more19 Jan 2021 16:30
EXECUTIVE CHANGE SUMMARY: Next CEO Wolfson Joins Board Of Deliveroo
EXECUTIVE CHANGE SUMMARY: Next CEO Wolfson Joins Board Of Deliveroo
Read more14 Jan 2021 14:55
DIRECTOR DEALINGS: Oncimmune Non-Exec Cheung To Sells 195,000 Shares
DIRECTOR DEALINGS: Oncimmune Non-Exec Cheung To Sells 195,000 Shares
Read more